drugset / Trial / NCT01939457

400mcg Sublingual Misoprostol as First Line Treatment

NCT01939457

Completed 641 enrolled Gynuity Health Projects
NaSingle-groupOpen-labelTreatment

Summary

Women presenting with incomplete abortion and eligible for treatment with misoprostol were offered 400mcg sublingual misoprostol for treatment. Based on existing literature, the study hypothesises that women can successfully be treated with misoprostol alone as first line treatment.

Timeline

Start
2011-09
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Other